Jose-Carlos (“JC”) is Senior Vice President and Chief Science Officer of Danaher. In this role, JC is responsible for setting Danaher’s science and technology strategy, supporting M&A and open innovation, and counseling Danaher’s operating companies on innovation opportunities. He leads the Danaher Innovation Centers and the Danaher Scientific Advisory Board. Working with technical leaders across Danaher, JC enables innovation best practice sharing and culture building.
“Science and technology is a powerful motivator for me and for many Danaher associates. We get up each day with a passion and goal to help solve our customers’ most complex challenges. Looking ahead the next five to ten years, we see tremendous opportunity to improve human health through scientific research and discovery.”
JC has diverse leadership experience across multiple biotech start-ups and pharmaceutical companies and deep expertise in translating new areas of science and technology into successful drug discovery and development programs and marketed drugs. Prior to Danaher, JC served as Global Head of Drug Discovery at AbbVie, Group SVP Biotherapeutics R&D at Pfizer and SVP and CEDD Head of Inmuno Inflammation at GlaxoSmithKline. JC was the founding CEO and President at Repertoire Immune Medicine where he built and led a team to decode the human immunome. Previously, he was President and CEO of Synlogic, where he led the company from early discovery to the clinical stage and to the public markets. In these global positions, he oversaw multiple drug discovery teams, resulting in five marketed drugs.
JC has a Ph.D. in immunology from the Universidad Autonoma de Madrid and trained as an immunologist in Spain, Germany and Switzerland. He started his academic career as Assistant Professor of Genetics at Harvard Medical School. He has authored more than 150 peer-reviewed publications.